Cargando…
Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia
BACKGROUND: Vincristine (VCR) is a major chemotherapy drug for treatment of childhood acute lymphoblastic leukemia (ALL). Triazole antifungal drugs (AFD) are the main agents for the prevention/treatment of invasive fungal infection (IFI), a common complication during the treatment of ALL. This study...
Autores principales: | Yang, Lihua, Yu, Lihua, Chen, Xinxin, Hu, Yanqun, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471853/ https://www.ncbi.nlm.nih.gov/pubmed/26050202 http://dx.doi.org/10.12659/MSM.893142 |
Ejemplares similares
-
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
por: Raj, Trisha A Soosay, et al.
Publicado: (2013) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Publicado: (2013) -
Posaconazole aggravates vincristine-related hypertension in children
with acute lymphoblastic leukemia: a case report
por: Lin, Chao, et al.
Publicado: (2020) -
Vincristine induced neurotoxicity in children who underwent chemotherapy for acute lymphoblastic leukemia and Wilms tumor
por: Adil, Muhammad Kamran, et al.
Publicado: (2021) -
Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2023)